Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 481761 - 481780 out of 495978 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (J05AP08) sofosbuvir (adm: O) | SOVALDI 400MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP08) sofosbuvir (adm: O) | SOVALDI 400MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP51) sofosbuvir and ledipasvir | HARVONI 33.75MG/150MG PKT PELLET,ORAL | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP51) sofosbuvir and ledipasvir | HARVONI 33.75MG/150MG PKT PELLET,ORAL | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP51) sofosbuvir and ledipasvir | HARVONI 45MG/200MG PKT PELLET,ORAL | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP51) sofosbuvir and ledipasvir | HARVONI 45MG/200MG PKT PELLET,ORAL | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP51) sofosbuvir and ledipasvir | HARVONI 45MG/200MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP51) sofosbuvir and ledipasvir | HARVONI 45MG/200MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP51) sofosbuvir and ledipasvir | HARVONI 90MG/400MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP51) sofosbuvir and ledipasvir | HARVONI 90MG/400MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP55) sofosbuvir and velpatasvir | EPCLUSA 150MG/37.5MG/PKT PELLET,ORAL | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP55) sofosbuvir and velpatasvir | EPCLUSA 150MG/37.5MG/PKT PELLET,ORAL | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP55) sofosbuvir and velpatasvir | EPCLUSA 200MG/50MG/PKT PELLET,ORAL | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP55) sofosbuvir and velpatasvir | EPCLUSA 200MG/50MG/PKT PELLET,ORAL | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP55) sofosbuvir and velpatasvir | EPCLUSA 200MG/50MG | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP55) sofosbuvir and velpatasvir | EPCLUSA 200MG/50MG | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP55) sofosbuvir and velpatasvir | EPCLUSA 400MG/100MG | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP55) sofosbuvir and velpatasvir | EPCLUSA 400MG/100MG | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP56) sofosbuvir, velpatasvir and voxilaprevir | VOSEVI | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
| USA | (J05AP56) sofosbuvir, velpatasvir and voxilaprevir | VOSEVI | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis C, Chronic | GileadSciences,Inc. |
Pages
